On 07.06.2015, a Memorandum of Understanding was signed between India and Netherland for the development of vaccines in India via technical support from a government-based institute of Netherland. The agreement was signed under ‘Make in India’ initiative of Government of India to enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL), a Central PSU under Department of Biotechnology, to develop Measles – Rubella vaccine at its plant at Chola, Bulandshahr, U.P. via technical support from Translational Vaccinology (INTRAVACC) a government-based institute of the Netherlands for the development of vaccine.
-Ministry of Science & Technology
Related
